BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38820939)

  • 1. Discovery of novel FUT8 inhibitors with promising affinity and in vivo efficacy for colorectal cancer therapy.
    Lv Y; Zhang Z; Wang M; Wang Y; Chen M; Jia J; Guo Y; Wang K; Li Z; Wang W; Li H
    Bioorg Chem; 2024 Aug; 149():107492. PubMed ID: 38820939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors.
    Wang X; Zhang C; Zhang X; Yan J; Wang J; Jiang Q; Zhao L; Zhao D; Cheng M
    Eur J Med Chem; 2020 May; 194():112243. PubMed ID: 32229389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of WZ4003 as NUAK inhibitors against human colorectal cancer.
    Yang H; Wang X; Wang C; Yin F; Qu L; Shi C; Zhao J; Li S; Ji L; Peng W; Luo H; Cheng M; Kong L
    Eur J Med Chem; 2021 Jan; 210():113080. PubMed ID: 33310286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LEF1-AS1/LEF1/FUT8 Axis Mediates Colorectal Cancer Progression by Regulating α1, 6-Fucosylationvia Wnt/β-Catenin Pathway.
    Qi Y; Shan Y; Li S; Huang Y; Guo Y; Huang T; Zhao X; Jia L
    Dig Dis Sci; 2022 Jun; 67(6):2182-2194. PubMed ID: 34021424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel cinnamaldehyde-based aspirin derivatives for the treatment of colorectal cancer.
    Lu S; Obianom ON; Ai Y
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2869-2874. PubMed ID: 30037494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer.
    Zhang W; Zhang K; Yao Y; Liu Y; Ni Y; Liao C; Tu Z; Qiu Y; Wang D; Chen D; Qiang L; Li Z; Jiang S
    Eur J Med Chem; 2021 Feb; 211():113022. PubMed ID: 33239261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of a Screening Hit toward M2912, an Oral Tankyrase Inhibitor with Antitumor Activity in Colorectal Cancer Models.
    Buchstaller HP; Anlauf U; Dorsch D; Kögler S; Kuhn D; Lehmann M; Leuthner B; Lodholz S; Musil D; Radtki D; Rettig C; Ritzert C; Rohdich F; Schneider R; Wegener A; Weigt S; Wilkinson K; Esdar C
    J Med Chem; 2021 Jul; 64(14):10371-10392. PubMed ID: 34255518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of quinazoline derivatives as a novel class of potent and in vivo efficacious LSD1 inhibitors by drug repurposing.
    Li Z; Qin T; Li Z; Zhao X; Zhang X; Zhao T; Yang N; Miao J; Ma J; Zhang Z
    Eur J Med Chem; 2021 Dec; 225():113778. PubMed ID: 34416665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chrysophanol exhibits inhibitory activities against colorectal cancer by targeting decorin.
    Deng M; Xue Y; Xu L; Wang Q; Wei J; Ke X; Wang J; Chen X
    Cell Biochem Funct; 2020 Jan; 38(1):47-57. PubMed ID: 31710116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 1-(5-(1H-benzo[d]imidazole-2-yl)-2,4-dimethyl-1H-pyrrol-3-yl)ethan-1-one derivatives as novel and potent bromodomain and extra-terminal (BET) inhibitors with anticancer efficacy.
    Kong B; Zhu Z; Li H; Hong Q; Wang C; Ma Y; Zheng W; Jiang F; Zhang Z; Ran T; Bian Y; Yang N; Lu T; Zhu J; Tang W; Chen Y
    Eur J Med Chem; 2022 Jan; 227():113953. PubMed ID: 34731760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of novel benzofuran derivatives as potent LSD1 inhibitors.
    Zhang X; Huang H; Zhang Z; Yan J; Wu T; Yin W; Sun Y; Wang X; Gu Y; Zhao D; Cheng M
    Eur J Med Chem; 2021 Aug; 220():113501. PubMed ID: 33945992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel artemisinin derivatives with potent activities against colorectal cancer in vitro and in vivo.
    Wang LL; Kong L; Liu H; Zhang Y; Zhang L; Liu X; Yuan F; Li Y; Zuo Z
    Eur J Med Chem; 2019 Nov; 182():111665. PubMed ID: 31494469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of the Antiproliferative and Antitumor Activity of Novel Telomerase-Carbonic Anhydrase Dual-Hybrid Inhibitors.
    Plyasova AA; Berrino E; Khan II; Veselovsky AV; Pokrovsky VS; Angeli A; Ferraroni M; Supuran CT; Pokrovskaya MV; Alexandrova SS; Gladilina YA; Sokolov NN; Hilal A; Carta F; Zhdanov DD
    J Med Chem; 2021 Aug; 64(15):11432-11444. PubMed ID: 34283610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of erythrina-based PARP-1/FTase dual-target inhibitors against lung cancer epithelial-mesenchymal transition (EMT) in vivo and in vitro.
    Yu L; Wang YD; Yan ZW; Zhang LY; Li S
    Bioorg Chem; 2024 Jul; 148():107480. PubMed ID: 38772291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and optimization of novel 6-acylamino-2-aminoquinolines as potent Hsp90 C-terminal inhibitors.
    Jiang F; Guo AP; Xu JC; Wang HJ; Mo XF; You QD; Xu XL
    Eur J Med Chem; 2017 Dec; 141():1-14. PubMed ID: 29028527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel heat shock protein (Hsp90) inhibitors based on luminespib with potent antitumor activity.
    Jung J; Kwon J; Hong S; Moon AN; Jeong J; Kwon S; Kim JA; Lee M; Lee H; Lee JH; Lee J
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127165. PubMed ID: 32305165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel potent migrastatic Thiazolo[5,4-b]pyridines targeting Lysyl-tRNA synthetase (KRS) for treatment of Cancer metastasis.
    Lee S; Kwon NH; Seo B; Lee JY; Cho HY; Kim K; Kim HS; Jung K; Jeon YH; Kim S; Suh YG
    Eur J Med Chem; 2021 Jun; 218():113405. PubMed ID: 33831781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel octapeptide-DTX prodrugs targeting MMP-7 as effective agents for the treatment of colorectal cancer with lower systemic toxicity.
    Liu ZY; Tang ML; Ning JF; Hao YP; Zhou L; Sun X
    Eur J Med Chem; 2020 May; 193():112194. PubMed ID: 32203786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel hydroxyamidine derivatives as indoleamine 2,3-dioxygenase 1 inhibitors with in vivo anti-tumor efficacy.
    Liu C; Nan Y; Xia Z; Gu K; Chen C; Dong X; Ju D; Zhao W
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127038. PubMed ID: 32088128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Urea Derivatives of Celastrol as Selective Peroxiredoxin 1 Inhibitors against Colorectal Cancer Cells.
    Li Y; Zhu Y; Shang FF; Xu L; Jiang D; Sun B; Zhang L; Luo C; Zhang A; Zhang H; Ding C
    J Med Chem; 2024 May; 67(9):7176-7196. PubMed ID: 38679872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.